Lv4
680 积分 2024-08-26 加入
Preclinical safety and efficacy characterization of an LpxC inhibitor against Gram-negative pathogens
1天前
已完结
Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology
19天前
已完结
Fibroblast and myofibroblast activation in normal tissue repair and fibrosis
22天前
已完结
Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial
1个月前
已完结
Mechanism of hepatobiliary toxicity of the LPA1 antagonist BMS-986020 developed to treat idiopathic pulmonary fibrosis: Contrasts with BMS-986234 and BMS-986278
1个月前
已完结
Belumosudil with ROCK-2 inhibition: chemical and therapeutic development to FDA approval for the treatment of chronic graft-versus-host disease
2个月前
已完结
Recent Progress toward the Discovery of Small Molecules as Novel Anti-Respiratory Syncytial Virus Agents
2个月前
已完结
Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition
3个月前
已完结
T-cell immunoglobulin and mucin-domain containing-3 (TIM-3): Solving a key puzzle in autoimmune diseases
4个月前
已完结
New epilepsy therapies in development
4个月前
已完结
皖公网安备34019202002308
